Diagnostic method for chronic fatigue syndrome by measuring elastase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 20, 2010
Grant Date -
Aug 14, 2008
app pub date -
Oct 6, 2004
filing date -
Sep 7, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to methods and kits for the diagnosis and confirmation of Chronic Fatigue Syndrome (CFS) by measuring elastase activity in a patient sample, preferably a PBMC sample. The assays of the invention can also be used to characterize CFS, to determine the disease stage, the disease progression, the efficiency of a therapeutic regime and/or to predict the recurrence of possible attacks. The assays of the invention advantageously allow CFS to be distinguished from other CICIDs like MS or RA.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully